Biotechnology News XIGRIS Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-3 out of 3 found

Current Search: xigris: 3

LILLY (ELI) & COMPANY - Lilly Reports Solid Second-Quarter Results
Lilly Reports Solid Second-Quarter Results Company reports double-digit sales and earnings growth Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2008.

Second-quarter results are presented on a...

Macro World Investor: Jul 24 2008 2:06PM
Matching: xigris

Find similar documents

Lilly Reports Solid Second-Quarter Results
Company reports double-digit sales and earnings growth INDIANAPOLIS, July 24 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY - News) today announced financial results for the second quarter of 2008.

Second-quarter results are...

Yahoo! Canada: Jul 24 2008 11:42AM
Matching: xigris

Find similar documents

Financial Report: Lilly 2Q
million (+44%) YTD Revenues: $10.0 billion (+12%) YTD Earnings: $2.0 billion (+73%) Comments: Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve, collectively grew 21% to $1.8 billion, and accounted for...

Contract Pharma: Jul 24 2008 6:45PM
Matching: xigris

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.